The hereditary cancer testing market size is estimated to reach US$ 9,840.52 million by 2027 from US$ 3,967.74 million in 2018; it is expected to grow at a CAGR of 11.1% during 2019–2027.
A hereditary cancer is any cancer caused by an inherited gene mutation. Harmful variants in some genes are known to be associated with an increased risk of developing cancer. Genetic testing helps in estimating an individual’s chance of developing cancer in his or her lifetime. This can be done by searching for mutations in one’s genes, chromosomes, or proteins. Genetic tests are available for a few types of cancer. These include breast cancer, ovarian cancer, colon cancer, thyroid cancer, prostate cancer, pancreatic cancer, melanoma, sarcoma, kidney cancer, and stomach cancer.
The hereditary cancer testing market trends is attributed due to rising focus over the R&D of the genetic testing to analyze the correlation of the cancer with the genetic sequence, increasing prevalence of hereditary cancer, and surge in the demand for DNA testing kits. However, stringent regulations over the diagnostics of the cancer may hinder the growth of market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hereditary Cancer Testing Market: Strategic Insights
Market Size Value in US$ 3,967.74 million in 2018 Market Size Value by US$ 9,840.52 million by 2027 Growth rate CAGR of 11.1% from 2019 to 2027. Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hereditary Cancer Testing Market: Strategic Insights
| Market Size Value in | US$ 3,967.74 million in 2018 |
| Market Size Value by | US$ 9,840.52 million by 2027 |
| Growth rate | CAGR of 11.1% from 2019 to 2027. |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions for Hereditary Cancer Testing Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Prevalence of Hereditary Cancer
Cancer is a genetic disorder caused due to definite variations in genes that govern cell functioning, particularly affecting their growth and replication. Hereditary genetic mutations are the cause of ~5–10% of all cancers. The researchers have related mutations in particular genes with more than 50 hereditary cancer syndromes affecting individuals in developing certain cancers. According to the World Health Organization, cancer caused ~9.6 million deaths worldwide in 2018. Further, as per the prediction of the National Cancer Institute, in 2018, ~1,735,350 new cancer cases would be diagnosed in the US. The increasing prevalence of breast cancer in the world is a huge concern. As per the World Health Organization, ~2.09 million cases of breast cancer were reported globally in 2018. However, according to breastcancer.org, in 2018, over 3.1 million women in the US were reported with a history of breast cancer.
Moreover, ~5–10% of breast cancers are related to the mutated genes inherited from parents. The variations in the BRCA1 and BRCA2 genes are prevalent. Women with a BRCA1 mutation have ~72% lifetime risk of developing breast cancer, while those with the BRCA2 mutation have ~69% risk of the same. Furthermore, APAC is facing the problem of the growing prevalence of cancer. China, Japan, India, Taiwan, South Korea, Malaysia, Singapore, Thailand, Philippines, Sri Lanka, Vietnam, Indonesia, Mongolia, Laos, and Cambodia are the major 15 nations with the large incidence of cancer. According to the data of the National Institute of Cancer Prevention and Research (NICPR), in 2018, cancer caused 784,821 deaths in India. Hence, the increasing prevalence of cancer drives the steady growth of hereditary cancer, thereby driving the growth of hereditary cancer testing market.
Diagnosis Type-Based Insights
The global hereditary cancer testing market, based on diagnosis type, is bifurcated into biopsy and imaging. The biopsy segment accounted for a larger share in 2018. However, the imaging segment is expected to witness a faster growth during 2019–2027. The biopsy segment is expected to grow owing to the rising prevalence of cancer, increasing demand for minimally invasive surgeries, initiatives undertaken by government & global health organizations.
Technology-Based Insights
The global hereditary cancer testing market, based on technology, is segmented into sequencing, PCR, and microarray. The sequencing segment was the largest among the technology subsegments in 2018 and is expected to continue to witness significant growth during 2019–2027. The sequencing segment is expected to grow owing to the allocation of funds by various government bodies and usage of NGS in the sequencing and targeted sequencing for multiple purposes, such as hereditary cancer detection.
End User-Based Insights
The global hereditary cancer testing market, based on end user, is segmented into diagnostic centers, hospital, and clinics. The diagnostic centers is expected to witness the highest growth over the forecast period. However, the hospital segment accounted for the largest share in 2018 and is expected to continue with a similar trend over the forecast period. The diagnostic centers segment is expected to grow owing to the accurate diagnosis and reduced risk of trial & error treatment. Genetic testing helps estimate the chances of developing cancer in one’s lifetime by searching for mutations in genes, chromosomes, or proteins.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the hereditary cancer testing market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. The hereditary cancer testing market share is anticipated to flourish with the development of new innovative products by market players. Some players operating in the market are Hologic Inc.; Koninklijke Philips N.V.; Quest Diagnostics Incorporated; Myriad Genetics, Inc.; Ambry Genetics; NeoGenomic Laboratories; Counsyl; Cancer Genetics Inc.; Invitae Corporation; Myogenes; Strand Life Sciences Pvt. Ltd.; Pathway Genomics Corporation; and CENTOGENE AG.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Diagnosis Type, Technology, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
In terms of end user, the global hereditary cancer testing market is segmented into diagnostic centers, hospital, and clinics. Among the above 4 segments, the diagnostic centers segment held the largest market share in 2018.
The hospital segment is estimated to grow at the fastest rate during the forecast period.
Problems in accessing whole genomic data for early detection is the major factor hindering the market growth.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Hereditary Cancer Testing Market – By Diagnosis Type
1.3.2 Global Hereditary Cancer Testing Market – By Technology
1.3.3 Global Hereditary Cancer Testing Market – By End User
1.3.4 Global Hereditary Cancer Testing Market – By Geography
2. Global Hereditary Cancer Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Hereditary Cancer Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions
4.4 Hereditary Cancer Testing - Price Analysis (US$)
4.5 Reimbursement Scenario (US)
4.6 Population Screening Data
5. Global Hereditary Cancer Testing Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Hereditary Cancer
5.1.2 Growing Awareness About Hereditary Cancer
5.2 Key Market Restraints
5.2.1 Problems in Accessing Whole Genomic Data for Early Detection
5.3 Key Market Opportunities
5.3.1 Growing Demand for Noninvasive Methods of Detection
5.4 Future Trends
5.4.1 Preference For Personalized Medicines
5.5 Impact Analysis
6. Hereditary Cancer Testing Market – Global Analysis
6.1 Global Hereditary Cancer Testing Market Revenue Forecasts And Analysis
6.2 Global Hereditary Cancer Testing Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players
7. Global Hereditary Cancer Testing Market Analysis– by Diagnosis Type
7.1 Overview
7.2 Global Hereditary Cancer Testing Market, By Diagnosis Type 2018 & 2027 (%)
7.3 Biopsy Market
7.3.1 Overview
7.3.2 Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 Blood Sample Market
7.3.3.1 Overview
7.3.3.2 Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Cheek Swab Sample Market
7.3.4.1 Overview
7.3.4.2 Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Imaging Market
7.4.1 Overview
7.4.2 Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global Hereditary Cancer Testing Market Analysis– by Technology
8.1 Overview
8.2 Global Hereditary Cancer Testing Market, By Technology 2018 & 2027 (%)
8.3 Sequencing Market
8.3.1 Overview
8.3.2 Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Polymerase Chain Reaction (PCR) Market
8.4.1 Overview
8.4.2 Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Microarray Market
8.5.1 Overview
8.5.2 Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
9. Global Hereditary Cancer Testing Market Analysis – by End User
9.1 Overview
9.2 Global Hereditary Cancer Testing Market, By End User 2018 & 2027 (%)
9.3 Diagnostic Centers Market
9.3.1 Overview
9.3.2 Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Hospitals Market
9.4.1 Overview
9.4.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Clinics Market
9.5.1 Overview
9.5.2 Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10. Hereditary Cancer Testing Market Revenue and Forecasts to 2027 – Geographical Analysis
10.1 North America Hereditary Cancer Testing Market
10.1.1 Overview
10.1.2 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.3.1 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.4 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.5 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.6 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.1.7 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.7.2.1 US Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.7.3 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.7.4 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.8 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.8.2.1 Canada Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.8.3 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.8.4 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.9 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.2 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.9.2.1 Mexico Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.9.3 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.9.4 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2 Europe Hereditary Cancer Testing Market
10.2.1 Overview
10.2.2 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.3 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.3.1 Europe Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.4 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.5 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.6 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.2.7 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.1 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.2 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.7.2.1 UK Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.7.3 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.7.4 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.8 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.1 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.2 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.8.2.1 Germany Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.8.3 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.8.4 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.9 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.1 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.2 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.9.2.1 France Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.9.3 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.9.4 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.10 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.1 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.2 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.10.2.1 Italy Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.10.3 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.10.4 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.11 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.1 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.2 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.11.2.1 Spain Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.11.3 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.11.4 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3 Asia Pacific Hereditary Cancer Testing Market
10.3.1 Overview
10.3.2 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.3 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.3.1 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.4 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.5 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.6 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.3.7 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7.1 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7.2 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.7.2.1 China Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.7.3 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.7.4 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.8 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.1 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.2 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.8.2.1 India Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.8.3 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.8.4 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.9 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.9.1 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.9.2 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.9.2.1 Japan Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.9.3 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.9.4 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.10 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.1 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.2 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.10.2.1 Australia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.10.3 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.10.4 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.11 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11.1 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11.2 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.11.2.1 South Korea Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.11.3 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.11.4 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4 Middle East & Africa Hereditary Cancer Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.3.1 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.4 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.5 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.6 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.4.7 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.1 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.2 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.7.2.1 South Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.7.3 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.7.4 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.8 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8.1 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8.2 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.8.2.1 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.8.3 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.8.4 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.9 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.1 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.2 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.9.2.1 UAE Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.9.3 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.9.4 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5 South And Central America Hereditary Cancer Testing Market
10.5.1 Overview
10.5.2 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.3 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.3.1 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.4 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.5.5 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5.6 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.5.7 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.7.1 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.7.2 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.7.2.1 Argentina Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.7.3 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.5.7.4 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5.8 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.1 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.2 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.8.2.1 Brazil Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.8.3 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.5.8.4 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Hereditary Cancer Testing Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
11.3 Organic Growth Strategies
11.3.1 Overview
11.3.2 Product Launch
11.3.3 Product Approval
11.3.4 Others
11.4 Inorganic Growth Strategies
11.4.1 Overview
11.4.2 Partnership
11.4.3 Agreement & Collaboration
11.4.4 Acquisition
12. Hereditary Cancer Testing Market–Key Company Profiles
12.1 Hologic Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Koninklijke Philips N.V.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Quest Diagnostics Incorporated
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Myriad Genetics, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cancer Genetics Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Invitae Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Myogenes
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Strand Life Sciences Pvt. Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Pathway Genomics Corporation
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 CENTOGENE AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. CPT Codes for Hereditary Cancer Tests
Table 2. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 3. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 4. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 5. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 6. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 7. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 8. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 9. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 10. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 11. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 12. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 13. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 14. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 15. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 16. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 17. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 18. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 19. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 20. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 21. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 22. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 23. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 24. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 25. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 26. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 27. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 28. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 29. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 30. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 31. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 32. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 33. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 34. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 35. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 36. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 37. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 38. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 39. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 40. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 41. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 42. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 43. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 44. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 45. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 46. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 47. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 48. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 49. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 50. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 51. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 52. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 53. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 54. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 55. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 56. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 57. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 58. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 59. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 60. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 61. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 62. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 63. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 64. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 65. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 66. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 67. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 68. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 69. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 70. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 71. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 72. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 73. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 74. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 75. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 76. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 77. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 78. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 79. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 80. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 81. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 82. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 83. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 84. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 85. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 86. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 87. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 88. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 89. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 90. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 91. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 92. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 93. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 94. Recent Product Launch in the Hereditary Cancer Testing Market
Table 95. Recent Product Approval in the Hereditary Cancer Testing Market
Table 96. Recent Other Growth Strategies in the Hereditary Cancer Testing Market
Table 97. Partnerships in the Hereditary Cancer Testing Market
Table 98. Agreement & Collaboration in the Hereditary Cancer Testing Market
Table 99. Acquisitions in the Hereditary Cancer Testing Market
Table 100. Glossary of Terms, Hereditary Cancer Testing Market
LIST OF FIGURES
Figure 1. Hereditary Cancer Testing Market Segmentation
Figure 2. Hereditary Cancer Testing Market Segmentation, by Region
Figure 3. Global Hereditary Cancer Testing Market Overview
Figure 4. Imaging Segment Held Largest Share Of The Diagnosis Type Segment In Hereditary Cancer Testing Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Hereditary Cancer Testing Market, By Geography (US$ Mn)
Figure 7. Global Hereditary Cancer Testing Market- Leading Country Markets (US$ Mn)
Figure 8. Global Hereditary Cancer Testing Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia - Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis of Driver and Restraints Pertaining to Hereditary Cancer Testing Market
Figure 15. Global Hereditary Cancer Testing Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 16. Global Hereditary Cancer Testing Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 17. Prominent Players in the Hereditary Cancer Testing Market
Figure 18. Global Hereditary Cancer Testing Market, by Diagnosis Type 2018 & 2027 (%)
Figure 19. Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global Hereditary Cancer Testing Market, by Technology 2018 & 2027 (%)
Figure 24. Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Global Hereditary Cancer Testing Market, by End User 2018 & 2027 (%)
Figure 28. Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. North America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 32. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 34. US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Europe Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 38. Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 40. UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Asia Pacific Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 46. Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 48. China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. Middle East & Africa Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 54. Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 56. South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 58. UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. South and Central America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 60. South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 62. Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 64. Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
Figure 65. Organic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
Figure 66. Inorganic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
The List of Companies
- Hologic Inc.
- Koninklijke Philips N.V.
- Quest Diagnostics Incorporated
- Myriad Genetics, Inc.
- Cancer Genetics Inc.
- Invitae Corporation
- Myogenes
- Strand Life Sciences Pvt. Ltd.
- Pathway Genomics Corporation
- CENTOGENE AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Hereditary Cancer Testing Market
Sep 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Sep 2019